During the past decade, MHAT Yuliya Vrevska Byala conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "MHAT Yuliya Vrevska Byala" are "Diabetes Mellitus" (3 trials) and "Gastroparesis" (3 trials). Many other conditions were trialed in "MHAT Yuliya Vrevska Byala" in a lesser frequency.

Most popular intervention types in "MHAT Yuliya Vrevska Byala" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials) and "Relamorelin" (3 trials). Other intervention names were less common.

The vast majority of trials in "MHAT Yuliya Vrevska Byala" are 3 trials for "All" genders.

Currently, there are NaN active trials in "MHAT Yuliya Vrevska Byala". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in MHAT Yuliya Vrevska Byala, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in MHAT Yuliya Vrevska Byala, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".